Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-2,800
Closed -$154K 6153
2020
Q4
$154K Sell
2,800
-1,800
-39% -$91.9K ﹤0.01% 5181
2020
Q3
$203K Buy
4,600
+4,200
+1,050% +$185K ﹤0.01% 4609
2020
Q2
$17K Hold
400
﹤0.01% 6727
2020
Q1
$16K Sell
400
-200
-33% -$8.46K ﹤0.01% 6809
2019
Q4
$27K Sell
600
-4,000
-87% -$154K ﹤0.01% 6766
2019
Q3
$157K Sell
4,600
-17,400
-79% -$602K ﹤0.01% 5335
2019
Q2
$828K Buy
22,000
+2,800
+15% +$95.8K ﹤0.01% 3863
2019
Q1
$587K Buy
+19,200
New +$586K ﹤0.01% 4010

Other funds holding ACA

Citigroup's ACA Position: Q1 2026 in Review

Citigroup reduced its Arcosa (ACA) stake by 65% in Q1 2026, selling an estimated $3.19M and leaving 14,962 shares worth $1.59M. The position accounts for ﹤0.01% of the portfolio, ranked #2820.

Citigroup first reported a position in ACA in Q4 2018 and has held it in 30 quarters since. The position peaked at $6.88M in Q4 2024. 372 funds tracked by Wall St. Rank hold ACA as of Q1 2026.

  • Citigroup held 14,962 shares of Arcosa worth $1.59M as of Q1 2026.
  • Citigroup sold 28,096 Arcosa shares in Q1 2026, an estimated $3.19M.
  • Arcosa made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #2820 holding.
  • Citigroup first reported a position in Arcosa in Q4 2018 and has held it in 30 quarters since.
  • Citigroup's Arcosa position peaked at $6.88M in Q4 2024.
  • 372 funds tracked by Wall St. Rank held Arcosa as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.